Unraveling Biomarker Signatures in Triple-Negative Breast Cancer: A Systematic Review for Targeted Approaches
Article in International Journal of Molecular Sciences (February 2024)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
PDLIM2 can inactivate the TGF‐β/Smad pathway to inhibit the malignant behavior of ovarian cancer cells
Article in Cell Biochemistry and Function (May 2023)
PDLIM2 is highly expressed in Breast Cancer tumour-associated macrophages and is required for M2 macrophage polarization
Article in Frontiers in Oncology (November 2022)